TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.

New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc. (“Takara Bio USA”), ...

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.

Exploring biology in its native environment is perhaps the ideal scenario for generating better hypotheses about the cellular interactions that influence—and drive—healthy and diseased states, ...

I have never felt so let down by the NHS, right from Owain’s diagnosis, through his treatment and in his death' ...

Novel nephron organoids that can be fine-tuned to represent the proximal convoluted tubule or loop of Henle have been ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

This valuable study investigates the role of HIF1a signaling in epicardial activation and neonatal heart regeneration in mice. Using a combination of genetic and pharmacological approaches, the ...

Besides hearing about some of the latest omics research from both academia and industry, the annual meeting of the American Society of Human Genetics (ASHG) is also the perfect opportunity to learn ...

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...